common. Paradoxically the higher the cesophagogastric anastomosis the less the regurgitation, while in the three-phase total cesophagectomy food intake is normal, and reflux almost unknown.
Survival rates: Review of the literature is difficult and confusing since much detail is not included in the published papers. The survival rates for all cases resected are shown in Table 4 , while variations in the survival rates for growths at various sites are shown in Table 5 .
An outstanding feature of the review of 276 cases in the Darlington/Northallerton series was the great wastage that occurred in the first postoperative year (Figs 4, 5 & 6) . If, however, the patients survived the second year the curve flattened out and the survival prospects improved. Another surprising feature was the better threeyear survival rate in the middle third (35.3 %) and in the upper lower third (36.4 %) , where the operation was by concept at least palliative, when compared with growths at the gastrocesophageal junction (21.6 %) where the operation was radical. This might be explained by the upper growths usually being squamous in type, while those at the cesophagogastric junction were often adenocarcinomata.
Intubation
The use of the indwelling Mousseau-Barbin tube has produced some degree of palliation, but has been somewhat disappointing. Only about half of the patients so intubated leave hospital.
Future Trends
The results of surgical treatment may well be improved by combination with radiotherapy. In the past, preoperative irradiation has been avoided because it causes difficulty in surgical dissection. On the other hand the vulnerability of the anastomosis to postoperative irradiation and the fear of unhealable stomata has restricted the use of X-ray therapy. In total three-phase cesophagectomy suspect hilar glands can be marked at operation by Michel's clips so that accurate direction of the X-ray beam is possible without danger to the cesophagogastric anastomosis (Fig 7) . Future developments may well be in the realms of combined therapy in which surgery, irradiation and chemotherapy will each play their part. Radiotherapy of Carcinoma of the (Esophagus Radiotherapy alone can challenge the best results obtained by surgery, but it should be stressed that the approach to the problem should always be a combined one, and that the optimum therapy should be considered for each patient, it being unlikely that any one form of treatment will be the best for all patients.
REFERENCES
No specific reference will be made to palliativetreatment, if only for the reason that so far as radiotherapy is concerned symptomatic relief requires an almost identical approach and very similar dosage to those which are required for radical treatment.
Incidence
Rather more than 50 new patients with carcinoma of the oesophagus present each year for every million of the general population. Thus in the Newcastle Regional Cancer Bureau registrations over the last twenty years have risen slowly from 160 to about 200 new patients per year. Cancer of the asophagus accounts for approximately 1 % of all cancers. It is a disease in which the incidence continues to rise into old age with a large number of patients over the age of 70: 10% are aged 50 or under, 47 % are 51-70, and 43 % are 70 or over.
Anatomy
The cesophagus runs a long course in close relationship to many major structures and for the greater part of its length is deeply buried within the thorax; the latter fact is probably a reason why patients seldom present with a very small carcinoma, and early involvement of important mediastinal structures is a common feature.
Pathology
(1) Rapidity of growth: The majority of patients have a relatively short history, usually of progressive dysphagia; some 45 % present within three months of the onset of symptoms, and only 10% give a history of twelve months or more.
(2) Histology: Of the tumours 90 % are squamous carcinomas but many are poorly differentiated, this fact correlating with the relative shortness of the history in the majority of patients and the very high proportion of patients whose tumour metastasizes to the regional lymph nodes. Some 10 % of the tumours are adenocarcinomas but not all of these are gastric in origin, but are related to the mucous glands in the middle and lower thirds of the cesophagus.
(3) Mode of spread: Local spread by direct continuity to structures in the neck and mediastinum is a common feature, and appears to be facilitated by the peristaltic movements in the oesophagus, and by the absence of a serosal coat. Extensive submucosal spread of the tumour is common, often involving lengths of 10 cm or more of the organ, and early invasion of the muscle coat is a feature. Lymphatic spread is also longitudinal in the initial stages, to involve paracesophageal nodes from the root of the neck distally to the nodes on the posterior abdominal wall.
The effects of these modes of spread of cesophageal cancer are well documented; Pearson reported that more than one-third of all patients at the time of presentation will have blood-borne metastases, distant lymphatic spread, a fistula, or a tumour in excess of 10 cm in length. Similarly, autopsy experience has shown that some 40 % of patients will have visceral metastases and some 17 % involvement of the distant lymphatic nodes. While the total length of the cesophagus involved by an individual carcinoma may be a greater limitation to the employment of radiotherapy than of surgery, local extension into adjacent tissues is more readily encompassed by radiotherapy than by surgery as there can be no question of a 'block' type of cancer operation.
Intercurrent Disease
While age per se is no absolute bar to the treatment of carcinoma of the cesophagus by either surgery or radiotherapy, it must be generally accepted that the greater the age of the patient the higher his chance of having an important intercurrent disease which may complicate his treatment by either modality or impair his chances of a satisfactory recovery.
Impaired Nutritional State
Whatever form of treatment is advocated for an individual patient, every effort must be made at the outset and throughout the period of treatment and convalescence, to improve and then maintain his nutritional state. The ideal which is usually attainable is to concentrate on a fluid diet which can be swallowed, and which with suitable additives can include all that is necessary in the way of calories, nutriment, electrolytes and vitamins. The second best choices are either naso-gastric intubation or intravenous alimentation, both of which can fulfil the above requirements, but neither solves the problem of swallowing of saliva. The undesirable last alternative is a gastrostomy which will of course solve the intake problem but does not help the swallowing of saliva in any way.
Newcastle Regional Experience
To take the year 1969 as an example, 182 patients were registered with the Regional Cancer Bureau as patients with carcinoma of the oesophagus. Some 33 % were not offered any active treatment at all, the majority not being referred to either a surgeon or a radiotherapist. Forty-two per cent were treated by surgery, 23 % with radical intent and 19 % as a palliative bypass procedure. Twenty-two per cent were treated by radiotherapy, and 3 % by a combined approach, these patients being those who had residual tumour at the end of an operation intended to be radical, and were given local radiotherapy to the affected area.
Of the whole population of 182, 8 % were alive at three years; this represents 12 % of those treated by either method, and 18% are those treated radically. Treatment Aims of treatment: The essential aim is to restore swallowing and avoid regurgitation of swallowed or ingested fluid, and also of natural saliva. No oncologist ever really wishes to aim at less than cure of his patient, but in carcinoma of the oesophagus, perhaps more than in many other tumours, it is necessary to consider the quality of life after treatment, as much as, if not even more than, length of life (Collis 1971) . In this respect two-year survival figures are relevant, as death due to cancer of the aesophagus is relatively uncommon more than two years after initial treatment (Parker et al. 1970) . In our experience, of the patients who die within two years of definitive therapy, 55% die with a local recurrence (27% within the first six months), 25% with distant metastases as the major cause of death, and some 20 % of other causes, particularly vascular disease or other cancer.
Methods of treatment:
The two major methods of treatment available are surgery and radiotherapy; chemotherapy and immunotherapy have not yet made any appreciable impact in the problem of carcinoma of the cesophagus and certainly do not yet enter the field of radical major treatments for this disease.
In this region, where the initial pattern of referral is primarily to a surgeon if thetumour is thought to be operable, only 23 % were treated by radical surgery, and 19 % were offered initial palliative surgery, a total of less than 50%.
Radiotherapy
Treatment by radiotherapeutic methods can be offered to at least two-thirds of all patients with carcinoma of the cesophagus (Pearson 1969 , also Newcastle experience above) and it is possible that some of the patients who are deemed untreatable and not referred to hospital might in fact benefit from palliative radiotherapy.
Specific indications for radiotherapy include the following: (1) The tumour is usually a squamous carcinoma, a tumour which in general is radiocurable, though unfortunately in carcinoma of the cesophagus many are poorly differentiated.
(2) The adjacent structures which may be either involved or closely apposed to the tumour, may tolerate radiotherapy better than surgery; in particular this refers to the heart, the great vessels and the lung and pleura, though care must be taken to avoid undue irradiation of the spinal cord.
(3) Radiotherapy is usually well tolerated.
(4) The regional lymph nodes will normally be included in the irradiated field and any potential metastases there may be controlled. (5) Radiotherapy has a considerably lower mortality and somewhat less morbidity than surgery.
On the other hand, the limitations of radiotherapy in patients with carcinoma of the oesophagus include: (1) The difficulty in some patients of treating an adequate length of the aesophagus (this is greater than the corresponding difficulty with surgery, though radiotherapy has the advantage of more effective treatment lateral and posterior to the aesophagus).
(2) The problem of balancing the volume to be irradiated and the dose to be given against the morbidity and endarteritic sequelh.
(3) The proximity to the spinal cord which sometimes makes treatment planning difficult. (4) The rather greater delay in achieving permanent correction of the nutritional problems of the patient. (5) The possibility of stricture formation, though this is considerably reduced when megavoltage beams are used in comparison with 250 kV X-rays or intracavitary radium.
With megavoltage X-ray equipment, dose distribution and protection of adjacent tissues and organs are adequate. The normal procedure is to use multiple fields with or without wedge filters, and the field arrangement varies according to the level of the cesophagus which is involved. Radiographic techniques are used in treatment planning and verification of the final field arrangement to ensure that an adequate volume of tissue surrounding the involved length of the cesophagus is being irradiated, and that such sensitive organs as the spinal cord are excluded from the high dose area. Treatment is normally fractionated in daily increments over a period of four to six weeks.
The major advantages of radiotherapy in the treatment of patients with carcinoma of the cesophagus include the retention of the normal stomach and larynx, and reduction in the early deaths as compared with surgery, the operative mortality of which varies from 12 % to 25%.
Results ofRadiotherapy
Less than a quarter of the patients in the Newcastle Region have been referred for radiotherapy and meaningful results cannot be obtained from such a small proportion. In patients with tumours in the upper and middle thirds of the oesophagus some 14% had initial treatment by surgery, supplemented by deep X-ray therapy for known residue at the end of the operation. The remainder of those irradiated had not had any previous surgical treatment. In the lower third of the aesophagus, the comparable figure for initial surgical treatment was 40 %. At all levels there is evidence in some patients of tumour regression and improvement in general condition associated with reduction of dysphagia.
More relevant is the experience of Pearson (1969) in Edinburgh where, for some ten years, all patients have been referred initially for, and treated by, radiotherapy, and who has been able to show that some 35 % of two-year survivals can be achieved, no matter at what level in the oesophagus the tumour arises.
Combination ofSurgery and Radiotherapy
As is the case in respect of combined treatment in any part of the body, any possible benefit to the patient from a combined approach must be balanced against the morbidity, particularly in respect of the vascular supply to the tumour and adjacent tissues, and the increased risk of ischemic or avascular late complications.
(1) Preoperative irradiation gives the doubtful possibility of increased operability, against which must be balanced the delay in obtaining an exact anatomical diagnosis, the delay in operation and therefore the increased possibility of metastases being produced, and the aggravation of any operative morbidity and technical problems. Some 85 % of patients having preoperative radiotherapy had residual tumour at operation (Parker et al. 1970 ).
(2) Postoperative radiotherapy can be considered in three ways: (a) Routine prophylactic treatment after an apparently successful operation. This is of very doubtful value. (b) Management of known residual tumour. This procedure has a definite indication particularly where the surgeon is able to label, e.g. by radio-opaque markers, the site of residual tumour and the anastomosis, which can be outside the field of irradiation. (c) Treatment of a later recurrence where there may be some difficulty in the exact localization of the whole mass of recurrent tumour. If the reconstituted alimentary canal has been intubated, e.g. by a Celestin or Mousseau-Barbin tube, the tube is unlikely to be adversely affected by the radiation itself but may be further constricted by postradiation scarring.
Conclusions
The surgical management of carcinoma of the upper two-thirds of the cesophagus is not entirely satisfactory and radiotherapy is at least as effective, with less mortality. Unless the surgeon is so highly selective that he scarcely makes a serious contribution to the overall management of the disease, the operative mortality is high. Experiences being accumulated suggest that after radiotherapy there is expectation of long survival in a higher proportion of patients than after surgery, largely because of the absence of treatment mortality.
In carcinoma of the lower third of the oesophagus, generally accepted as the best site for surgery, radiotherapy may be equally effective, especially for those over the age of 65, or for those who are poor surgical risks. Those patients who do survive after radiotherapy have a normal voice and a normal stomach, and therefore seldom have problems with nutrition.
Furthermore, radiotherapeutic efforts are often of considerable palliative value and may be iustified on this basis alone. A limited number of long-term survivals will be obtained when treatment is planned, as it must be, with this possibility in mind.
